SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031428
Filing Date
2017-05-10
Accepted
2017-05-10 11:47:32
Documents
63
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8916_110q.htm 10-Q 973711
2 EX-31.1 a17-8916_1ex31d1.htm EX-31.1 10739
3 EX-31.2 a17-8916_1ex31d2.htm EX-31.2 10731
4 EX-32.1 a17-8916_1ex32d1.htm EX-32.1 5353
5 EX-32.2 a17-8916_1ex32d2.htm EX-32.2 5401
  Complete submission text file 0001104659-17-031428.txt   3260665

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adap-20170331.xml EX-101.INS 481531
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adap-20170331.xsd EX-101.SCH 39859
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adap-20170331_cal.xml EX-101.CAL 44281
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adap-20170331_def.xml EX-101.DEF 83358
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT adap-20170331_lab.xml EX-101.LAB 280835
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adap-20170331_pre.xml EX-101.PRE 200133
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 17829147
SIC: 2836 Biological Products, (No Diagnostic Substances)